Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity

Effect of NKG2D ligand expression on host immune responses

(2015) Marine Champsaur et al.   IMMUNOLOGICAL REVIEWS

Cutting Edge: Down-Regulation of MHC Class I-Related Chain A on Tumor Cells by IFN- -Induced MicroRNA

(2014) D. Yadav et al.   JOURNAL OF IMMUNOLOGY

miR-155 regulates IFN-  production in natural killer cells

(2012) R. Trotta et al.   BLOOD

Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells

(2012) Jianwei Zhang et al.   CYTOTECHNOLOGY

Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses

(2012) J. Hilpert et al.   JOURNAL OF IMMUNOLOGY

MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing Radiation

(2012) Zhongxing Liang et al.   PHARMACEUTICAL RESEARCH

The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1

(2012) N. Cai et al.   RNA

Human NKG2D-ligands: cell biology strategies to ensure immune recognition

(2012) Lola Fernández-Messina et al.   Frontiers in Immunology

Vitamin D and Cancer

(2012) Laura Vuolo et al.   Frontiers in Endocrinology

A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans

(2011) Shigeru Tsuboi et al.   EMBO JOURNAL

1,25-Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

(2011) Ji H. Lee et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer

(2011) Hiroaki Saito et al.   Gastric Cancer

NKG2D and its ligands: Key to immunotherapy of liver cancer?

(2011) Mario U. Mondelli   JOURNAL OF HEPATOLOGY

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

(2011) I Keklikoglou et al.   ONCOGENE

Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy

(2010) Donald L. Trump et al.   CANCER JOURNAL

Activating and inhibitory receptors of natural killer cells

(2010) Hollie J Pegram et al.   IMMUNOLOGY AND CELL BIOLOGY

IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46

(2010) Maya Eisenring et al.   NATURE IMMUNOLOGY

Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21

(2009) Sefa Kizildag et al.   ANNALS OF HEMATOLOGY

NKG2D and its ligands

(2009) Peyman Obeidy et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

(2008) Nadia Guerra et al.   IMMUNITY

Cancer Immunosurveillance: NKG2D Breaks Cover

(2008) Hans-Gustaf Ljunggren   IMMUNITY

NKG2D ligands in tumor immunity

(2008) N Nausch et al.   ONCOGENE